(Q30398056)

English

Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

0 references

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

Nicola Principi

11

object named as

Nicola Principi

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Susanna Esposito

1

object named as

Susanna Esposito

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Laura Tagliaferri

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Cristina Daleno

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Antonia Valzano

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Irene Picciolli

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Francesca Tel

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Giulia Prunotto

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Domenico Serra

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Carlotta Galeone

9

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Anna Plebani

10

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

1 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1677-1682

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Susceptibility to influenza A in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Influenza in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

The rational use of influenza vaccines in healthy children and children with underlying conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Large trials confirm immunogenicity of H1N1 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Response to a monovalent 2009 influenza A (H1N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

A novel influenza A (H1N1) vaccine in various age groups.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Humoral and Cellular Response to Influenza Vaccine in HIV-Infected Children With Full Viroimmunologic Response to Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to [...]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.047

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.12.047

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30398056&oldid=1794335288"